Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol + Bupivacaine for IANB in Irreversible Pulpitis
NCT03749408Phase 3Completed
- Sponsor
- Cairo University
- Start
- Dec 2012
- Primary completion
- Jun 2014
- Modality
- Inhalation Devices, Small Molecules
01
Overview
Phase 3, randomised trial of Bronchitol in irreversible pulpitis (2 arms), sponsored by Cairo University. Primary endpoint: Postoperative pain intensity at 72 hours. Started Dec 2012; status: completed.
02
Drugs
Bronchitol
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT03749408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03749408.